Compare, Analyse Divis Laboratories with ADCOCK INGRAM HOLDINGS LTD. - S. Africa - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DIVIS LABORATORIES vs ADCOCK INGRAM (S. Africa) - Comparison Results

DIVIS LABORATORIES     Change

Established in the year 1990, Divi's Laboratories has been focusing on CRAMS and is an established player in the custom chemical synthesis (CCS) and API/Intermediate segment. Around 50% of Divi's revenues are derived from custom manufacturing for glo... More

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 DIVIS LABORATORIES   ADCOCK INGRAM
EQUITY SHARE DATA
    DIVIS LABORATORIES
Mar-19
ADCOCK INGRAM
Jun-14
DIVIS LABORATORIES/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs1,639351-   
Low Rs1,115253-   
Sales per share (Unadj.) Rs186.3104.4-  
Earnings per share (Unadj.) Rs51.0-26.3-  
Cash flow per share (Unadj.) Rs57.3-21.8-  
Dividends per share (Unadj.) Rs16.000-  
Dividend yield (eoy) %1.20-  
Book value per share (Unadj.) Rs261.881.9-  
Shares outstanding (eoy) m265.47168.78-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x7.42.9 255.5%   
Avg P/E ratio x27.0-11.5 -235.4%  
P/CF ratio (eoy) x24.0-13.9 -173.4%  
Price / Book Value ratio x5.33.7 142.7%  
Dividend payout %31.40-   
Avg Mkt Cap Rs m365,59250,974 717.2%   
No. of employees `00011.84.3 276.0%   
Total wages/salary Rs m5,4233,199 169.5%   
Avg. sales/employee Rs Th4,175.14,103.8 101.7%   
Avg. wages/employee Rs Th457.7745.2 61.4%   
Avg. net profit/employee Rs Th1,141.8-1,034.1 -110.4%   
INCOME DATA
Net Sales Rs m49,46317,618 280.8%  
Other income Rs m1,556123 1,261.5%   
Total revenues Rs m51,01917,741 287.6%   
Gross profit Rs m18,718-3,053 -613.1%  
Depreciation Rs m1,689760 222.1%   
Interest Rs m35477 7.3%   
Profit before tax Rs m18,551-4,167 -445.2%   
Minority Interest Rs m0-12 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m5,023260 1,929.1%   
Profit after tax Rs m13,527-4,439 -304.7%  
Gross profit margin %37.8-17.3 -218.4%  
Effective tax rate %27.1-6.2 -433.4%   
Net profit margin %27.3-25.2 -108.5%  
BALANCE SHEET DATA
Current assets Rs m46,50112,903 360.4%   
Current liabilities Rs m8,4687,260 116.6%   
Net working cap to sales %76.932.0 240.0%  
Current ratio x5.51.8 309.0%  
Inventory Days Days131111 117.9%  
Debtors Days Days86124 69.3%  
Net fixed assets Rs m25,7977,521 343.0%   
Share capital Rs m53182 649.1%   
"Free" reserves Rs m68,9620-   
Net worth Rs m69,49313,828 502.6%   
Long term debt Rs m04,859 0.0%   
Total assets Rs m80,38326,122 307.7%  
Interest coverage x531.0-7.7 -6,867.6%   
Debt to equity ratio x00.4 0.0%  
Sales to assets ratio x0.60.7 91.2%   
Return on assets %16.9-15.2 -111.2%  
Return on equity %19.5-32.1 -60.6%  
Return on capital %26.7-19.8 -135.0%  
Exports to sales %00-   
Imports to sales %24.60-   
Net fx Rs m28,8330-   
CASH FLOW
From Operations Rs m9,5431,504 634.6%  
From Investments Rs m-6,854-462 1,484.4%  
From Financial Activity Rs m-2,4594,410 -55.8%  
Net Cashflow Rs m2305,452 4.2%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 4.84 Rs / ZAR

Compare DIVIS LABORATORIES With: ACTAVIS (US)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare DIVIS LABORATORIES With: PIRAMAL ENTERPRISES  GLENMARK PHARMA  CADILA HEALTHCARE  J.B.CHEMICALS  PANACEA BIOTECH  



Today's Market

Sensex Tanks 531 Points; Reliance Industries & IndusInd Bank Fall 5%(Closing)

Indian share markets witnessed huge selling pressure today and failed to hold on to their opening gains as profit booking and weakness across all sectors erased gains.

Related Views On News

DIVIS LABORATORIES Announces Quarterly Results (1QFY21); Net Profit Up 84.1% (Quarterly Result Update)

Aug 10, 2020 | Updated on Aug 10, 2020

For the quarter ended June 2020, DIVIS LABORATORIES has posted a net profit of Rs 5 bn (up 84.1% YoY). Sales on the other hand came in at Rs 17 bn (up 50.0% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.

DIVIS LABORATORIES Announces Quarterly Results (4QFY20); Net Profit Up 35.4% (Quarterly Result Update)

Jun 8, 2020 | Updated on Jun 8, 2020

For the quarter ended March 2020, DIVIS LABORATORIES has posted a net profit of Rs 4 bn (up 35.4% YoY). Sales on the other hand came in at Rs 14 bn (up 9.5% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.

DIVIS LABORATORIES 2018-19 Annual Report Analysis (Annual Result Update)

Oct 10, 2019 | Updated on Oct 10, 2019

Here's an analysis of the annual report of DIVIS LABORATORIES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of DIVIS LABORATORIES. Also includes updates on the valuation of DIVIS LABORATORIES.

More Views on News

Most Popular

Time to Book Profits in Pharma Stocks (Fast Profits Daily)

Jan 15, 2021

In this video, I'll show you why it might be the right time to take money of the table in pharma stocks.

Smallcap Stocks: Your Best Bet for 2021 and Beyond (Profit Hunter)

Jan 15, 2021

The pandemic failed to thwart Richa's investing success formula for 2020.

Buzzing Sectors Before Budget 2021 (Fast Profits Daily)

Jan 12, 2021

The budget is just a few weeks away. Which stocks can you expect to move? Find out in this video.

Here's Why Smallcaps Could Be Your Best Investment in 2021 (Profit Hunter)

Jan 12, 2021

Select smallcaps hold a great potential to become the multibaggers of tomorrow. Here's how you could get in early into these stocks.

More
-->

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

Free Report: Multibagger Stock Ideas 2021
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

DIVIS LABORATORIES SHARE PRICE


Jan 25, 2021 (Close)

TRACK DIVIS LABORATORIES

  • Track your investment in DIVIS LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DIVIS LABORATORIES

DIVIS LABORATORIES 8-QTR ANALYSIS

COMPARE DIVIS LABORATORIES WITH

FEATURED VIDEOS

Smallcap Revival: Should You Wait, Keep Holding, or Buy Now?

Crucial Week Ahead for the Indian Stock Market

Great vs Good: Which Stock Will Win in 2021?

Safest Assets in 2021 are Not What You Think...

More Featured Videos

MARKET STATS